Attention Deficit Hyperactivity Disorder Market Size To Expand At A Healthy Growth Rate Of CAGR 6.4% During The Forecast Period 2019 to 2025: Grand View Research,Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
According to report published by Grand View Research,Increase in awareness regarding ADHD among patients, physicians, and other healthcare providers is likely to up demand for effective treatment, in turn, propelling ADHD market growth.

According to a report ,“Attention Deficit Hyperactivity Disorder (ADHD) Market Analysis Report By Drug Type (Stimulant, Non-stimulant), By Demographic, By Distribution Channel (Hospital & Retail Pharmacy), And Segment Forecasts, 2019 – 2025” published by Grand View Research, Inc., The global attention deficit hyperactivity disorder market size is expected to reach USD 24.9 billion by 2025, exhibiting a 6.4% CAGR during the forecast period. Increase in awareness regarding ADHD among patients, physicians, and other healthcare providers is likely to up demand for effective treatment, in turn, propelling market growth.

Key Takeaways from the report:

  • Increasing access to health insurance for mental health treatment and rising incidence of ADHD are expected to propel market growth in the coming years

  • By drug type, the stimulant drugs segment accounted for the largest share in the market in 2018 and is anticipated to maintain its dominance during the forecast period. This can be attributed to effectiveness of drugs in treating of ADHD symptoms and commercialization of new drugs

  • Based on demographics, adults held the maximum share in the ADHD market in 2018 due to high prevalence of the condition across the globe, increased awareness about mental health, and launch of effective drugs with minimum adverse effects

  • By distribution channel, retail pharmacy accounted for the largest share in 2018 due to increasing number of prescriptions. This can be attributed to rise in patient care initiatives by retail pharmacies

  • Geographically, North America dominated the global ADHD market in 2018 owing to high awareness of mental health, increasing patient population, and local presence of market players

  • Asia Pacific is anticipated to observe significant growth during the forecast period owing to government initiatives to provide effective treatment for ADHD and rising patient population due to stressful lifestyle

  • Some of the key players in the market are Eli Lily & Company; Pfizer; Johnson & Johnson Services, LLC; Lupin; Shire; Mallinckrodt; Prude Pharma L.P.; and NEOS Therapeutics Inc.

U.S. attention deficit hyperactivity disorder (ADHD) market size, by drug type, 2014 - 2025 (USD Billion)

Browse More Reports in Pharmaceuticals Industry:

  • Veterinary/Animal Vaccines Market : Rise in the outbreak of livestock diseases, expanding livestock population and increasing zoonotic diseases are driving the veterinary/Animal vaccines market growth. Increasing awareness regarding commercially available vaccines is pushing the adoption globally. 
  • Ophthalmic Therapeutics/Drugs Market : Increase in funding by public and private bodies for conducting research on ocular disorders with the presence of strong emerging pipeline drugs are some of the factors responsible for the growth of ophthalmic therapeutics market.

Global ADHD market share, by distribution channel, 2018 (%)

Furthermore, there has been a steady rise in ADHD patients during the last 20 years. According to a study conducted by the National Health Interview Survey, the prevalence of ADHD among children and adolescents in U.S. rose from 6.1% in 1997-1998 to 10.2% in 2015-2016.

Approval and commercialization of drugs, increase in number of clinical trials, and rise in awareness regarding diagnosis and treatment of the condition is expected to boost market growth over the forecast period.

Grand View Research has segmented the global ADHD market by drug type, demographic, distribution channel, and region:

ADHD Drug Outlook (Market Revenue in USD Million, 2014 – 2025)

  • Amphetamine

  • Methylphenidate

  • Lisdexamfetamine

  • Dexmethylphenidate

  • Atomoxetine

  • Guanfacine

  • Clonidine

  • Bupropion

ADHD Drug Type Outlook (Market Revenue in USD Million, 2014 – 2025)

  • Stimulant

  • Non-stimulant

ADHD Demographic Outlook (Market Revenue in USD Million, 2014-2025)

  • Adult (Aged 18 and above)

  • Children

ADHD Distribution Channel Outlook (Market Revenue in USD Million, 2014-2025)

  • Retail Pharmacy

  • Hospital Pharmacy

ADHD Regional Outlook (Market Revenue in USD Million, 2014 – 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • Middle East and Africa

    • South Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grad View Research, Inc.

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information:

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland